Biomarkers for diagnosing alzheimer's disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8772042
APP PUB NO 20120016205A1
SERIAL NO

13099110

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific peptide markers, e.g., using mass spectrometric analysis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER HEALTHCARE AGLEVERKUSEN 51368

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carrette, Odile Roubaix, FR 3 10
Hochstrasser, Denis Francois Collonge-Bellerive, CH 14 52
König, Gerhard Newton, US 2 9
Sanchez, Jean-Charles Geneva, CH 20 97
Yalkinoglu, Özkan Wuppertal, DE 3 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 8, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00